News

Nerve repair device house Orthocell is taking a cautious approach to entering the US market, with a staged approach to ...
Several ASX-listed biotechs are advancing cell therapies to capture a share of a global market projected to reach US$48 ...
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
Verity Resources (ASX:VRL) has appointed Xirlatem and Dr Rick Gordon to oversee expansion plans at Verity's Monument Gold Project.
Donald Trump again has threatened a tariff on imported drugs, but has given the drug makers a year or so "to get their act ...
Argent Minerals (ASX:ARD) has unlocked 1.8km of previously uncharted gold strike at its Trunkey Creek gold project in New ...
QMines (ASX:QML) has upgraded its Mount Mackenzie gold and silver resource base and raised the bar on its multi-asset production aspirations.
EchoIQ’s heart-failure AI just hit Mayo’s testing track, chasing FDA clearance and a shot at fixing America’s $60bn hospital headache.
Stockhead’s Tylah Tully looks at the latest from HyTerra Limited (ASX:HYT), who are preparing to spud the next well at its Nemaha helium project in Kansas. The McCoy-1 Well will be spudded this week, ...
The ASX fell sharply in afternoon trade but then found its way to a level footing following the RBA's cash rate hold.
South African gold output has steadily declined for three decades. Record prices and political stability are bringing the ...
Dental supplier SDI's full-year revenue has been crimped by an ongoing migration from amalgam fillings that contain mercury.